Risks vs Benefits for SGLT2 Inhibitor Medications.

Fed Pract

is a Resident at Mercy Saint Vincent Medical Center in Toledo, Ohio. is a Research Scholar, and is an Emeritus Professor, both at the University of Louisville in Kentucky. is a Resident at the Griffin Memorial Hospital in Norman, Oklahoma.

Published: July 2018

AI Article Synopsis

Article Abstract

Health care providers should carefully assess patients with diabetes mellitus before prescribing sodium-glucose cotransporter 2 inhibitor medications and monitor for adverse effects.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368009PMC

Publication Analysis

Top Keywords

inhibitor medications
8
risks benefits
4
benefits sglt2
4
sglt2 inhibitor
4
medications health
4
health care
4
care providers
4
providers carefully
4
carefully assess
4
assess patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!